Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Upgrading Food Testing Laboratories: Minister informs Parliament

      Upgrading Food Testing Laboratories: Minister informs Parliament

      Ruby Khatun Khatun13 Aug 2017 9:42 AM IST
      The Minister of State (Health and Family Welfare), Sh Faggan Singh Kulaste through a written reply in the Rajya Sabha informed about the upgradations...
      Cipla hopes to generate sustainable top-line growth in FY18

      Cipla hopes to generate sustainable top-line growth in FY18

      Ruby Khatun Khatun13 Aug 2017 9:20 AM IST
      Mumbai: Cipla on Friday said even as the industry faces several hurdles, the government's new drug policy will boost the pharma sector and the company...
      Mylan cuts forecasts on delays in new drugs, weak prices

      Mylan cuts forecasts on delays in new drugs, weak prices

      Ruby Khatun Khatun13 Aug 2017 9:10 AM IST
      Mylan NV said on Wednesday that delays in launching key new drugs and eroding prices for generics in the United States will hurt its profitability...
      Indian-origin biotech entrepreneur Vivek Ramaswamy firm Roivant raises 1.1 billion dollar from SoftBank

      Indian-origin biotech entrepreneur Vivek Ramaswamy firm Roivant raises 1.1 billion dollar from SoftBank

      Ruby Khatun Khatun12 Aug 2017 12:25 PM IST
      BASEL, Switzerland and LONDON, United Kingdom: Roivant Sciences announced a $1.1 billion equity investment led by the SoftBank Vision Fund. This...
      Lupin appoints Manju Deshbandhu Gupta as Chairman

      Lupin appoints Manju Deshbandhu Gupta as Chairman

      Ruby Khatun Khatun12 Aug 2017 12:23 PM IST
      New Delhi: Drug major Lupin appointed Manju Deshbandhu Gupta as Chairman of the company with immediate effect.The company's board unanimously...
      Zydus Pharma recalls 3.31 lakh bottles of seizure drug in US

      Zydus Pharma recalls 3.31 lakh bottles of seizure drug in US

      Ruby Khatun Khatun12 Aug 2017 12:20 PM IST
      New Delhi: Zydus Pharmaceuticals USA Inc is recalling from the US market over 3.31 lakh bottles of Divalproex Sodium delayed release tablets used for...
      Sun Pharma buys stake in US based biopharma company

      Sun Pharma buys stake in US based biopharma company

      Ruby Khatun Khatun12 Aug 2017 9:40 AM IST
      Mumbai: Drug maker, Sun Pharma has acquired 15.9% stake in US-based biopharmaceutical company, Krystal Biotech Inc.One of the wholly-owned...
      Quality standards prescribed in pharmacopoeias mandatory for manufacturing of AYUSH drugs: Shri Shripad Naik

      Quality standards prescribed in pharmacopoeias mandatory for manufacturing of AYUSH drugs: Shri Shripad Naik

      Ruby Khatun Khatun12 Aug 2017 9:40 AM IST
      The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik through a written reply to a question in Lok Sabha informed that the...
      LifeCell Becomes Indias Biggest Cord Blood Stem Cell Registry for Unrelated Use

      LifeCell Becomes Indias Biggest Cord Blood Stem Cell Registry for Unrelated Use

      Ruby Khatun Khatun12 Aug 2017 9:20 AM IST
      Achieves landmark milestone within four months of launch of revolutionary banking modelCHENNAI: In spite of being a highly populated country, India...
      Billionaire father and son duo turned Cadila Healthcare into world beater

      Billionaire father and son duo turned Cadila Healthcare into world beater

      Ruby Khatun Khatun11 Aug 2017 10:00 AM IST
      By Ari AltstedterIf the stock market is any guide, Sharvil Patel has just inherited one of the top generic drug manufacturers in the world. Now, he...
      Aster DM Healthcare re-files for  IPO

      Aster DM Healthcare re-files for IPO

      Ruby Khatun Khatun11 Aug 2017 9:36 AM IST
      Mumbai: A draft red herring prospectus (DRHP) has been re-filled by Aster DM Healthcare with a reduced offer size of its initial public offering...
      Sun Pharma drops over 5 percent; shares hit 52-week low

      Sun Pharma drops over 5 percent; shares hit 52-week low

      Ruby Khatun Khatun11 Aug 2017 9:25 AM IST
      New Delhi: Shares of Sun Pharmaceutical Industries fell by over 5 per cent amid reports that its subsidiary Taro Pharmaceutical Industries reported...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok